Dr. Rajeeve is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
530 East 74th Street
New York, NY 10021
Summary
- Physician-investigator with a clinical and research interest in plasma cell dyscrasias (Multiple Myeloma, Precursor states - MGUS/SMM, Amyloidosis, Waldenstrom's Macroglobulinemia, POEMS Syndrome etc.), cellular therapeutics, clinical trials, digital health technologies and healthcare delivery transformation.
Education & Training
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 2020 - 2023- Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2017 - 2020
Mahatma Gandhi UniversityClass of 2015, Bachelor of Medicine and Bachelor of Surgery (MBBS), Valedictorian
Certifications & Licensure
NJ State Medical License 2023 - 2025
NY State Medical License Active through 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- Educational Commission for Foreign Medical GraduatesECFMG
Awards, Honors, & Recognition
- Domestic Scholar Award AIDS Malignancy Consortium
- Young Investigator Award (YIA) American Society of Clinical Oncology (ASCO), 2022
- HONORS Award and Grant American Society of Hematology (ASH)
Publications & Presentations
PubMed
- The landscape of clinical trials for heavily pretreated multiple myeloma: opportunity for more randomization?Rohan Kapur, John McCarron, Sridevi Rajeeve, Ghulam Rehman Mohyuddin
Leukemia & Lymphoma. 2024-10-20 - 1 citationsAccelerating accessibility of CAR-T/NK therapies - Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?Sridevi Rajeeve, Abhinav Hoskote, Sham Mailankody
Seminars in Hematology. 2024-10-01 - Addition of Elotuzumab to Backbone Treatment Regimens for Multiple Myeloma: An Updated Meta-Analysis of Randomized Clinical Trials.Bruno Almeida Costa, Thomaz Alexandre Costa, Gabriel Cavalcante Lima Chagas, Tarek H Mouhieddine, Joshua Richter
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-21
Abstracts/Posters
- Myelodysplastic Syndromes: Trends in Mortality, Costs of Hospitalizations, Length of Stay and Rate of ComplicationsSridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Pegaspargase Can Safely be Administered in Adults Age 40 and Older with Acute Lymphoblastic LeukemiaSridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Acute Myeloid Leukemia and Cirrhosis: Trends in Utilization of Induction Chemotherapy, Rate of Hospitalizations and MortalitySridevi Rajeeve, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Professional Memberships
- Member
- Member
- Member
- European Hematology AssociationMember
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
